Published in JALA Charlottesv Va on June 01, 2008
Automated high-throughput microchannel assays for cell biology: Operational optimization and characterization. JALA Charlottesv Va (2010) 1.18
Asymmetric-detection time-stretch optical microscopy (ATOM) for ultrafast high-contrast cellular imaging in flow. Sci Rep (2014) 0.93
A new multicolor bioluminescence imaging platform to investigate NF-κB activity and apoptosis in human breast cancer cells. PLoS One (2014) 0.81
Expanding the utility of beta-galactosidase complementation: piece by piece. Mol Pharm (2010) 0.80
Temperature gradients drive radial fluid flow in Petri dishes and multiwell plates. AIChE J (2016) 0.75
Small molecules as therapeutic agents for inborn errors of metabolism. J Inherit Metab Dis (2016) 0.75
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen (1999) 32.67
Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem (2004) 2.45
A simple technique for reducing edge effect in cell-based assays. J Biomol Screen (2003) 1.86
Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists. Am J Physiol Cell Physiol (2001) 1.68
An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. Biochem Biophys Res Commun (2004) 1.56
A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Res (2006) 1.50
A standard operating procedure for assessing liquid handler performance in high-throughput screening. J Biomol Screen (2002) 1.34
High-throughput cell analysis using multiplexed array technologies. Drug Discov Today (2002) 0.94
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb) (2009) 2.58
Antituberculosis activity of the molecular libraries screening center network library. Tuberculosis (Edinb) (2009) 1.94
A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Res (2006) 1.50
Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure. Clin Vaccine Immunol (2009) 1.44
High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb) (2011) 1.23
Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library. J Biomol Screen (2006) 1.18
High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2). J Biomol Screen (2008) 1.15
A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase. J Biomol Screen (2006) 1.14
Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen. J Biomol Screen (2010) 0.97
Assay development and high-throughput antiviral drug screening against Bluetongue virus. Antiviral Res (2009) 0.96
Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors. Bioorg Med Chem (2011) 0.95
Exercise-induced pain requires NMDA receptor activation in the medullary raphe nuclei. Med Sci Sports Exerc (2012) 0.92
High-throughput screening identifies a bisphenol inhibitor of SV40 large T antigen ATPase activity. J Biomol Screen (2011) 0.91
HTS-driven discovery of new chemotypes with West Nile Virus inhibitory activity. Molecules (2010) 0.91
Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus. J Med Chem (2014) 0.89
Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits. Bioorg Med Chem (2008) 0.88
A high-throughput screening assay for inhibitors of bacterial motility identifies a novel inhibitor of the Na+-driven flagellar motor and virulence gene expression in Vibrio cholerae. Antimicrob Agents Chemother (2011) 0.87
(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection. J Med Chem (2012) 0.86
A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus. Virol J (2013) 0.85
Identification of novel small molecule activators of nuclear factor-κB with neuroprotective action via high-throughput screening. J Neurosci Res (2011) 0.83
A high-throughput screening strategy to overcome virus instability. Assay Drug Dev Technol (2010) 0.82
A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells. J Biomol Screen (2011) 0.81
Primary and secondary drug screening assays for Friedreich ataxia. J Biomol Screen (2011) 0.80
High-throughput RNA interference screening: tricks of the trade. J Lab Autom (2013) 0.80
Exercise prevents development of autonomic dysregulation and hyperalgesia in a mouse model of chronic muscle pain. Pain (2016) 0.79
A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus. Assay Drug Dev Technol (2014) 0.79
Screening methods for influenza antiviral drug discovery. Expert Opin Drug Discov (2012) 0.79
Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activity. J Med Chem (2014) 0.79
The NIH's role in accelerating translational sciences. Nat Biotechnol (2012) 0.79
A high-throughput screen for chemical inhibitors of exocytic transport in yeast. Chembiochem (2010) 0.78
A highly specific cell-based high-throughput screening assay for ligands of cyclic adenosine monophosphate receptor protein in gram-negative bacteria. Assay Drug Dev Technol (2013) 0.75
Polymerization of C-terminally truncated Mycobacterium tuberculosis FtsZ is unlikely to be physiologically relevant. Microbiology (2004) 0.75
NIH: translation centre bridges a gap. Nature (2011) 0.75
Adapting high-throughput screening methods and assays for biocontainment laboratories. Assay Drug Dev Technol (2015) 0.75
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. bioRxiv (2020) 0.75
Development of multiplex DNA electronic microarrays using a universal adaptor system for detection of single nucleotide polymorphisms. Biotechniques (2004) 0.75